Recent Updates
Recently added Catalysts
SRTA Positive Sentiment Score: 75/100

Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution $30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject

Key Takeaway: Strata Critical Medical, Inc. has announced the closing of a $30 million revolving credit facility with JPMorgan Chase Bank to support its acquisition strategy. This facility can be increased to $50 million under certain conditions, providing the company with enhanced capital efficiency for future acquisitions. Moreover, Strata's owned aircraft will remain unencumbered, yielding options for additional financing. The company aims to leverage its proven acquisition strategy to further accelerate growth in the medical logistics sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Strata has secured a $30 million credit facility to support acquisitions.
  • The facility can potentially be increased to $50 million, enhancing financial flexibility.
  • The company maintains unencumbered owned aircraft, allowing for future financing options.
  • Strata has a strong track record of successful acquisitions which may accelerate growth.

Full Press Release Details

Strata Announces Closing of Revolving Credit Facility to Support
Acquisition Strategy Execution
$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions
Owned aircraft excluded from collateral package and remain unencumbered
New York, Feb 5, 2026 -- Strata Critical Medical, Inc. (Nasdaq:
SRTA, "Strata" or the "Company"), a leading provider of logistics and medical services in the organ transplant
industry, today announced that the Company has entered into a credit agreement with JPMorgan Chase Bank, N.A. for secured, asset-based
revolving credit loans in aggregate principal amount of up to $30.0 million, which, subject to certain conditions, may be increased up
to an aggregate of $50.0 million (the "ABL Facility").
"This facility will improve Strata's capital efficiency,
enabling deployment of more cash towards attractive acquisition opportunities," said Amir Cohen, Strata's Chief Accounting
and Integration Officer. "By leaving our owned aircraft fleet unencumbered, we are maintaining significant optionality for additional
financing in the future."
"We have a strong track record of successful tuck-in acquisitions
in the clinical perfusion space," said Mat Schneider, CFO of Strata's Clinical division and VP, IR. "This new facility
will enable us to continue executing on our time-tested playbook to accelerate growth."
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to
the U.S. healthcare industry. We operate one of the nation's largest air transport and surgical services networks for transplant
hospitals and organ procurement organizations, offering an integrated "one call" solution for donor organ recovery.
Strata's core services include air and ground logistics, surgical
organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment
solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit www.srta.com.

Frequently Asked Questions

What is the amount of Strata's new revolving credit facility?

Strata's new revolving credit facility amounts to $30 million.

Can the credit facility be increased beyond $30 million?

Yes, it can be increased to $50 million under certain conditions.

Are Strata's owned aircraft included in the collateral?

No, Strata's owned aircraft are excluded and remain unencumbered.

Who is the CFO of Strata's Clinical division?

Mat Schneider is the CFO of Strata's Clinical division.

What services does Strata provide in the healthcare industry?

Strata offers logistics, surgical organ recovery, and perfusion services.

Last updated: Feb 5, 2026